Your browser doesn't support javascript.
loading
Eculizumab and ravulizumab in the treatment of refractory antiphospholipid syndrome-a first case report.
Antovic, A; Faustini, F; Karandyszovska, N; Svenungsson, E; Yilmaz, E B; Bruzelius, M; Gunnarsson, I.
Afiliação
  • Antovic A; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Faustini F; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Karandyszovska N; Department of Medicine Solna, Karolinska Institutet and Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Svenungsson E; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Yilmaz EB; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Bruzelius M; Department of Medicine Solna, Karolinska Institutet and Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Gunnarsson I; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Rheumatology (Oxford) ; 2024 Jul 02.
Article em En | MEDLINE | ID: mdl-38954804
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Ano de publicação: 2024 Tipo de documento: Article